Clinical Trials Browser

Ivermectin × 90 days × Clear all

NCT05318469 2026-05-06

Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer

Phase 1/2 Recruiting

Triple Negative Breast Neoplasms

NCT07487805 2026-03-23

ICONIC

Phase 2 Not yet recruiting

Neoplasms